News

New Whish Deodorant Swipes designed to prevent odor in one swipe

BY Antoinette Alexander

NEW YORK — Whish Body Products has developed a new natural deodorant swipe that promises to refresh and prevent odor in one swipe.

The Whish Deodorant Swipe uses saccharomyces ferment to prevent odor, which is an alternative to the metals and alloys found in some other store bought deodorants. It has a light fragrance that is understated enough to use with perfume or lotion or as a standalone clean scent.

In addition to the prevention of unwanted odor, the hair-inhibiting properties of Whish’s Shave Savour Hair Inhibiting Gel have been infused in these wipes to prevent and inhibit hair growth, the company stated.

The Whish Deodorant Swipes are available in two sizes: in a 30-pack for $22 or an 8-pack for $7.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

NACDS urges ‘commonsense’ approaches to Medicare reform in statement to lawmakers

BY Antoinette Alexander

ARLINGTON, Va. — The National Association of Chain Drug Stores is urging lawmakers to examine “commonsense, pro-patient, pro-pharmacy reforms” in an effort to modernize the Medicare program for beneficiaries.

In a statement NACDS sent to the U.S. House of Representatives Committee on Ways and Means Subcommittee on Health, the Association is urging “commonsense” approaches to Medicare reform and emphasizing community pharmacy’s role in improving heath and controlling costs.

NACDS submitted the comments in response to a request from the committee for stakeholder reactions on bipartisan proposals on entitlement reform.  
Citing medication therapy management, expanded coverage of vaccines in Part D and increasing utilization of generic drugs, NACDS provided specific examples of preventive approaches to improved patient health and cost-savings within the Medicare program.

“Through personal interactions with patients, face-to-face consultations and convenient access to preventive care services, local pharmacists are helping to shape the healthcare delivery system of tomorrow — in partnership with doctors, nurses and others,” NACDS said in its statement. “Pharmacists also provide vital patient care through services, such as medication therapy management (MTM) and their expanded role in providing immunizations.”

Reports by the Congressional Budget Office and the Centers for Medicare & Medicaid Services, as well as a recent article in Health Affairs found that appropriate medication use can in fact improve health while lowering costs, NACDS stated. These findings have helped increase recognition by lawmakers on the value of MTM, including bipartisan support for U.S. House and U.S. Senate bills, the Medication Therapy Management Empowerment Act of 2013 (H.R. 1024 and S. 557, respectively). The House bill currently has 127 co-sponsors and the Senate bill has 23 co-sponsors.

In addition, encouraging Medicare patients and others to obtain vaccinations at their neighborhood pharmacy is a cost-effective and convenient way to help prevent illness and reduce healthcare costs. The Department of Defense cites cost savings of nearly $1.5 million by expanding the portfolio of vaccines that Tricare patients may obtain from community pharmacies. Currently all 50 states allow pharmacists to provide certain immunizations, and NACDS continues to work to expand vaccination opportunities for pharmacists.

In its statement, NACDS also emphasized the benefits of increased utilization of generic drugs and the ability for Medicare patients to choose where they wish to obtain their medications and pharmacy services.

“Pharmacists have long promoted generic drugs as safe, cost-effective alternatives for many patients. Community pharmacy has a higher rate of generic dispensing — 73% — than any other practice setting,” NACDS said in its statement.

NACDS estimates that in the Medicaid program, for every 1% increase in generic utilization, approximately $809 million in federal and state dollars would be saved.

“Substituting generic pharmaceuticals for their brand-name equivalents is an effective way to achieve significant savings in public and private healthcare programs,” NACDS said in its statement.

“NACDS and the chain pharmacy industry are committed to partnering with Congress, the Centers for Medicare and Medicaid Services, patients and other healthcare providers to improve quality and affordability of the Medicare program,” NACDS said in its statement.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Study finds NJoy e-cigarette use can help short-term smoking reduction and cessation potential

BY Jason Owen

SCOTTSDALE, Ariz. — NJoy today announced the results of a pilot study that has been accepted for publication in the American Journal of Health Behavior and will be published online on October 1, 2013. The study, supported by NJoy and led by independent researchers Mitchell Nides, Ph.D. and Scott Leischow, Ph.D. evaluated nicotine delivery from the NJoy Kings Bold Electronic Delivery System (ENDS) and its short-term potential for smoking reduction or cessation. Results indicated that the NJoy Kings Bold ENDS delivered nicotine at a rate comparable to some FDA-approved nicotine replacement therapy products and that use of the product during the course of the one-week study led to short-term smoking reduction.

The open-label study, consisting of 25 smokers ages 18 years to 65 years who were not interested in quitting, found:

  • Mean daily cigarette smoking decreased from the baseline week to the trial week in 89% of subjects, with a statistically significant mean reduction in cigarettes smoked per day of 39%.
  • Smoking was reduced by 50% or more in 32% of subjects.
  • 16% of subjects had reduced their consumption of cigarettes to zero by the end of the study period.
  • Subjects had generally favorable perceptions of the NJoy Kings product at the end of the one-week trial period, with more than half reporting “high satisfaction” with a number of product features.

The results suggest that the NJoy Kings product delivered enough nicotine to suppress craving and was generally liked. However, the small number of subjects and short one-week testing period limit the study’s efficacy. Thus, while the results indicated that the NJoy Kings product has potential for use in smoking reduction and cessation, larger trials are needed.

“NJoy is actively engaged in expanding the science base on the health effects of electronic cigarettes and their potential to reduce the harms associated with traditional tobacco cigarettes,” said Dr. Richard Carmona, former Surgeon General of the United States and the chair of NJoy’s Scientific Advisory Committee. “These preliminary findings underscore the need for further research on the category and its potential for harm reduction.”


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?